Page 23 - HOH

Miami Cancer Institute Now Offering Stem

Cell Transplantations

6 HORA PASA , 10 DI JANUARI 2019 15:18
SECCION: SALUD

Miami Cancer Institute Now Offering Stem Cell Transplantations

The Blood & Marrow Transplant program recently received approval of a certificate of need from

the state

MIAMI, FL – December 21, 2018 – Miami Cancer Institute, part of Baptist Health South Florida,
is offering autologous stem cell transplants for patients with multiple myeloma and lymphoma on
an outpatient basis, a procedure that spares patients weeks of hospitalization, often in isolation,
and promotes recovery. The Institute also began performing inpatient autologous transplants for

more complex cases in November of this year at Miami Cancer Institute.

“Being at home with loved ones and staying active can lead to better outcomes in certain
patients,” said Guenther Koehne, M.D., Ph.D., an internationally renowned blood cancer expert

and Miami Cancer Institute’s chief of Blood & Marrow Transplantation and Hematologic
Oncology.

Under Dr. Koehne’s direction, the Institute already has performed several outpatient and
inpatient autologous stem cell transplants for patients with multiple myeloma, Non-Hodgkin’s
lymphoma and Hodgkin’s disease, in which the patient’s own stem cells are collected and then

reintroduced. Allogeneic transplants, which use stem cells from a donor, are indicated for
patients with leukemia, myelodysplastic and myeloproliferative disorders and are more complex
procedures which always require hospitalization. These procedures will be performed at Miami
Cancer Institute starting February of 2019 upon completion of a new state-of-the-art stem cell

processing and immunotherapy laboratory.

Miami Cancer Institute’s Blood and Marrow Transplant program recently received approval of a
certificate of need from the state’s Agency for Health Care Administration. The program
expands inpatient stem cell transplant options in South Florida for patients with leukemia, non-
Hodgkin’s lymphoma, multiple myeloma and other blood cancers.